Cargando…
Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545889/ https://www.ncbi.nlm.nih.gov/pubmed/37784247 http://dx.doi.org/10.1002/ctm2.1430 |
| _version_ | 1785114759588216832 |
|---|---|
| author | Guo, Tianxing Wang, Zhaofeng Wang, Song Zhang, Yaru Pang, Jiaohui Ying, Yajun Ou, Qiuxiang Shen, Dong Li, Gang |
| author_facet | Guo, Tianxing Wang, Zhaofeng Wang, Song Zhang, Yaru Pang, Jiaohui Ying, Yajun Ou, Qiuxiang Shen, Dong Li, Gang |
| author_sort | Guo, Tianxing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10545889 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105458892023-10-04 Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy Guo, Tianxing Wang, Zhaofeng Wang, Song Zhang, Yaru Pang, Jiaohui Ying, Yajun Ou, Qiuxiang Shen, Dong Li, Gang Clin Transl Med Letter to the Journal John Wiley and Sons Inc. 2023-10-02 /pmc/articles/PMC10545889/ /pubmed/37784247 http://dx.doi.org/10.1002/ctm2.1430 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Journal Guo, Tianxing Wang, Zhaofeng Wang, Song Zhang, Yaru Pang, Jiaohui Ying, Yajun Ou, Qiuxiang Shen, Dong Li, Gang Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy |
| title | Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy |
| title_full | Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy |
| title_fullStr | Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy |
| title_full_unstemmed | Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy |
| title_short | Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy |
| title_sort | predictive value of dot1l mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy |
| topic | Letter to the Journal |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545889/ https://www.ncbi.nlm.nih.gov/pubmed/37784247 http://dx.doi.org/10.1002/ctm2.1430 |
| work_keys_str_mv | AT guotianxing predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT wangzhaofeng predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT wangsong predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT zhangyaru predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT pangjiaohui predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT yingyajun predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT ouqiuxiang predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT shendong predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy AT ligang predictivevalueofdot1lmutationsforclinicaloutcomesinnonsmallcelllungcancerpatientsreceivingimmunecheckpointinhibitortherapy |